Literature DB >> 7642724

Developmental changes in the activity and cellular localization of hepatic casein kinase II in the rat.

P A Gruppuso1, J M Boylan.   

Abstract

The activity and cellular localization of hepatic casein kinase II (CKII) was examined during late fetal development in the rat. Cultured fetal hepatocytes displayed constitutive CKII activity which was not further activated by growth factor exposure. Similarly, fetal liver CKII showed approximately fivefold greater activity than adult liver. The fetal hepatic activity was, to a large degree, localized to a nuclear fraction. Postnuclear cytosol preparations from fetal and adult liver showed similar CKII activity. In all cases, FPLC ion exchange chromatography followed by Western immunoblotting showed that immunoreactive CKII coincided with kinase activity. However, parallel determinations of CKII activity and immunoreactive CKII levels showed a higher (five- to sixfold) CKII specific activity in nuclear extracts compared to cytosol. In summary, fetal hepatic CKII demonstrates coincident nuclear localization and activation. We hypothesize that the regulation of hepatic CKII is relevant to the mitogen-independent proliferation displayed by fetal rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642724     DOI: 10.1002/jcb.240580109

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Antisense expression of the CK2 alpha-subunit gene in Arabidopsis. Effects on light-regulated gene expression and plant growth.

Authors:  Y Lee; A M Lloyd; S J Roux
Journal:  Plant Physiol       Date:  1999-03       Impact factor: 8.340

2.  Modulation of mitogen-independent hepatocyte proliferation during the perinatal period in the rat.

Authors:  P A Gruppuso; M Awad; T C Bienieki; J M Boylan; S Fernando; R A Faris
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

3.  Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein.

Authors:  Miwako Kato Homma; Dongxia Li; Edwin G Krebs; Yasuhito Yuasa; Yoshimi Homma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

4.  Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.

Authors:  M A Morsy; J Z Zhao; T T Ngo; A W Warman; W E O'Brien; F L Graham; C T Caskey
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.